Legend Biotech (LEGN) Short-term Investments (2020 - 2025)
Legend Biotech's (LEGN) quarterly Short-term Investments came in at $70000.0 in Q2 2025, up 100.05% YoY from $34991.9 in Q2 2024, and little changed on a QoQ basis from $70000.0 in Q1 2025.
Legend Biotech (LEGN) Short-term Investments (2020 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 6 years of Short-term Investments data on file, last reported at $70000.0 in Q2 2025.
- Quarterly Short-term Investments rose 100.05% year-over-year to $70000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $70000.0 (up 100.05% YoY) and the FY2024 annual result came in at $70000.0, down 89.44% from the prior year.
- Short-term Investments was little changed at $70000.0 in Q2 2025, from $70000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $185.8 million in Q3 2023 to a low of -$160.0 million in Q3 2022.
- A 5-year average of $14.6 million and a median of $70000.0 in 2024 frame the typical range for Short-term Investments.
- The widest YoY moves for Short-term Investments: up 471.21% in 2022, down 419.74% in 2022.
- Tracing LEGN's Short-term Investments over 5 years: stood at -$50.0 million in 2021, then soared by 471.21% to $185.6 million in 2022, then tumbled by 99.64% to $663000.0 in 2023, then slumped by 89.44% to $70000.0 in 2024, then changed by 0.0% to $70000.0 in 2025.
- The last three Short-term Investments figures came in at $70000.0 (Q2 2025), $70000.0 (Q1 2025), and $70000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | -149.80 Mn |
| Jun 30, 2024 | -150.56 Mn |
| Mar 31, 2024 | 150.45 Mn |
| Dec 31, 2023 | 663,000.00 |
| Sep 30, 2023 | 185.79 Mn |
| Jun 30, 2023 | 185.76 Mn |
| Mar 31, 2023 | 185.71 Mn |
| Dec 31, 2022 | 185.60 Mn |
| Sep 30, 2022 | -160.00 Mn |
| Jun 30, 2022 | -100.00 Mn |
| Mar 31, 2022 | -100.00 Mn |
| Dec 31, 2021 | -50.00 Mn |
| Sep 30, 2021 | 50.04 Mn |
| Dec 31, 2020 | -22.68 Mn |
| Sep 30, 2020 | -20.43 Mn |
| Jun 30, 2020 | 18.50 Mn |